Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Blood
|
August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis
Elodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Blood
|
May 18, 2017
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults
Paul Milne, Venetia Bigley, Chris M Bacon, et al.
Nature Communications
|
May 19, 2017
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
Jean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, et al.
Blood Advances
|
October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
Blood
|
May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Oussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Cancers
|
November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester Disease
Ran Weissman, Eli L Diamond, Julien Haroche, et al.
Nature
|
March 15, 2019
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Eli L Diamond, Benjamin H Durham, Gary A Ulaner, et al.
Cell Stem Cell
|
September 10, 2019
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation
Aaron D Viny, Robert L Bowman, Yu Liu, et al.
Nature Medicine
|
June 9, 2016
Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee, Heidi Dvinge, Eunhee Kim, et al.
Nature Medicine
|
May 3, 2016
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee, Heidi Dvinge, Eunhee Kim, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Blood
|
August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis
Elodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Blood
|
May 18, 2017
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults
Paul Milne, Venetia Bigley, Chris M Bacon, et al.
Nature Communications
|
May 19, 2017
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
Jean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, et al.
Blood Advances
|
October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
Blood
|
May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Oussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Cancers
|
November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester Disease
Ran Weissman, Eli L Diamond, Julien Haroche, et al.
Nature
|
March 15, 2019
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Eli L Diamond, Benjamin H Durham, Gary A Ulaner, et al.
Cell Stem Cell
|
September 10, 2019
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation
Aaron D Viny, Robert L Bowman, Yu Liu, et al.
Nature Medicine
|
June 9, 2016
Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee, Heidi Dvinge, Eunhee Kim, et al.
Nature Medicine
|
May 3, 2016
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee, Heidi Dvinge, Eunhee Kim, et al.
Page
of 7